REVIEW PAPER
Diagnostic criteria for metabolic syndrome: A historical overview
 
More details
Hide details
1
Department of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland
2
Clinic of Endocrinology, Diabetology and Internal Medicine, Provincial Specialist Hospital in Olsztyn, Poland
CORRESPONDING AUTHOR
Magdalena Szychlińska   

Mroza 23a/64, 10-692 Olsztyn, Poland. Tel.:+48 503 938 335.
Submission date: 2020-07-16
Final revision date: 2020-09-15
Acceptance date: 2020-09-15
Online publication date: 2020-11-04
 
Pol. Ann. Med. 2020;27(2):244–249
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Although attempts to establish a definition of metabolic syndrome (MS) intensified two decades ago, research into diseases co-occurring with MS was initiated as early as in the 17th century. The breakthrough came in 1988 with a study by Gerald M. Reaven, which combined so far unrelated conditions into X syndrome. In the 20th and 21st century, research focused on providing a definition applicable in clinical practice.

Aim:
The following overview summarizes the history of MS, from early descriptions to the most recent attempts at defining it.

Material and methods:
The literature was searched in PubMed, Scopus, and Google Scholar databases focusing on history of research on MS, criteria of diagnosis.

Results and discussion:
Since 1998, while the concept of MS was accepted, the definition has evolved. Since the European Group for the Study of Insulin Resistance definition was announced, the essential components of diagnosing MS have not changed, they have only been specified to include a greater part of the population. It seems that MS is not only a pathophysiological term, but also a practical-clinical one. When diagnosed, it involves further medical treatment.

Conclusions:
(1) The definition of MS has evolved, becoming simplified so that it can be used in clinical practice. (2) Main components of diagnosing MS have been specified to include a greater part of the population. (3) It seems that MS is not only a pathophysiological term, but also a practical-clinical one. (4) The construct of MS definition has inherent limitations which impact on its clinical usefulness. (5) The current definition might be subject to more modifications following new research studies.

CONFLICT OF INTEREST
The authors have no potential conflicts of interest.
FUNDING
The work was not financed by any scientific research institution, association or other entity, the authors did not receive any grant.
 
REFERENCES (39)
1.
Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Lancet. 2005;366 (9491):1059–1062. https://doi.org/10.1016/s0140-....
 
2.
Grundy SM, Cleeman JI, Daniels SR, et al.; AHA, NHLBI. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752. https://doi.org/10.1161/circul....
 
3.
Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31(9):1898–1904. https://doi.org/10.2337/dc08-0....
 
4.
Ley SH, Harris SB, Mamakeesick M, et al. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community. CMAJ. 2009;180(6):617–624. https://dx.doi.org/10.1503%2Fc....
 
5.
Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR. Glycaemia (hemoglobin A1c) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol. 2005;4(12):821–826. https://doi.org/10.1016/s1474-....
 
6.
Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med. 1989;149(7):1514–1520. https://doi.org/10.1001/archin....
 
7.
Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20(2):157–172. https://doi.org/10.1093/oxford....
 
8.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. https://doi.org/10.1002/(sici)....
 
9.
Erkelens DW, de Bruin TW, Caberaz M. Tulp syndrome. Lancet. 1993;342(8886–8887):1536–1537. https://doi.org/10.1016/S0140-....
 
10.
Enzi G, Busetto L, Inelmen EM, et al. Historical perspective: Visceral obesity and related comorbidity in Joannes Baptista Morgagni’s ‘De sedibus et causis morborum per anatomen indagata’. Int J Obes Relat Metab Disord. 2003;27(4):534– 535. https://doi.org/10.1038/sj.ijo....
 
11.
Kylin E. Studien über das Hypertonie–Hyperglykamie–Hyperurikämiensyndrom. Z Inn Med. 1923;44:105–127 [in German].
 
12.
Węgierko J. The practical importance of dividing diabetes into its individual forms. Pol Arch Med Wewn. 1955;25:791–797 [in Polish].
 
13.
Vague J. The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4(1):20–34. https://doi.org/10.1093/ajcn/4....
 
14.
Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. https://doi.org/10.2337/diab.3....
 
15.
Reaven G. The metabolic syndrome: Requiescat in pace. Clin Chem. 2005;51(6):931–938. https://doi.org/10.1373/clinch....
 
16.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553. https://doi.org/10.1002/(sici)....
 
17.
Balkau B, Charles MA, Drivsholm T, et al.; European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28(5):364–376.
 
18.
Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–636. https://doi.org/10.1161/ATVBAH....
 
19.
Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: Definition and controversies. BMC Med. 2011; 9(48):1–13. https://doi.org/10.1186/1741-7....
 
20.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285(19):2486–2497. https://doi.org/10.1001/jama.2....
 
21.
National Institutes of Health, National Heart, Lung, and Blood Institute, NHLBI Obesity Education Initiative, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication. 2000;10(4084):1–94.
 
22.
Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237–252.
 
23.
Alberti KGM, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366(9491):1059–1062. https://doi.org/10.1016/S0140-....
 
24.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(suppl 1): s5–s10. https://doi.org/10.2337/diacar....
 
25.
Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752. https://doi.org/10.1161/circul....
 
26.
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. https://doi.org/10.1161/circul....
 
27.
Reaven GM. The metabolic syndrome: Time to get off the merry-go-round? J Intern Med. 2011;269(2):127–136. https://doi.org/10.1111/j.1365....
 
28.
Ford E. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care. 2005;28(7):1769–1778. https://doi.org/10.2337/diacar....
 
29.
Wu HW, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: A meta-analysisof prospective cohort studies. Eur J Epidemiol. 2010;25(6):375–384. https://doi.org/10.1007/s10654....
 
30.
Stefanowicz-Rutkowska M, Myszka-Podgórska K, Matuszewski W, Baranowska A, Modzelewski R, Bandurska-Stankiewicz E. A new look at the polycystic ovary syndrome. Pol Ann Med. 2019;26(1):60–65. https://doi.org/10.29089/2017.....
 
31.
Zachariah J, Quiroz R, Nelson K, et al. Prospective relation of circulating adipokines to incident metabolic syndrome: The Framingham heart study. J Am Heart Assoc. 2017:6(7):e004974. https://dx.doi.org/10.1161%2FJ....
 
32.
Kumari R, Kumar S, Kant R. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome. Diab Met Syn Res Rev. 2019;13(4):2409–2417. https://doi.org/10.1016/j.dsx.....
 
33.
Xu K, Zhu HJ, Chen S, et al. Fat-to-muscle ratio: A new anthropometric indicator for predicting metabolic syndrome in the Han and Bouyei populations from Guizhou Province, China. Biomed Environ Sci. 2018;31(4):261–271. https://doi.org/10.3967/bes201....
 
34.
Kurinami N, Sugiyama S, Yoshida A, et al. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016;120:65–72. https://doi.org/10.1016/j.diab....
 
35.
Ramírez-Vélez R, Correa-Bautista J, Sanders-Tordecilla A, et al. Percentage of body fat and fat mass index as a screening tool for metabolic syndrome prediction in Colombian University students. Nutrients. 2017;9(9):1009. https://doi.org/10.3390/nu9091....
 
36.
Sreckovic B, Sreckovic D, Soldatovic I, et al. Homocysteine is a marker for metabolic syndrome and atherosclerosis. Diabetes Metab Syndr. 2017;11(3):179–182. https://doi.org/10.1016/j.dsx.....
 
37.
Simmons R, Alberti G, Gale E, et al. The metabolic syndrome: Useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53(4):600–605. https://doi.org/10.1007/s00125....
 
38.
Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289–2304. https://doi.org/10.2337/diacar....
 
39.
Chaychenko T. Risk related cardiovascular changes in metabolically healthy obese adolescents. Pol Ann Med. 2016;23(2):87–91. https://doi.org/10.1016/j.poam....